What supplement removes plaque from arteries?

The regression ruler: the two instruments that measure whether a plaque has shrunk, what regression looks like when it happens, and the only two things that have moved the needle on either

What supplement removes plaque from arteries is a question with a verb in it that has to be earned, and it is earned on a ruler. A plaque is measured by two instruments. The first is intravascular ultrasound, a probe threaded inside a coronary artery during a catheter procedure that measures the plaque's volume and composition directly, which is the instrument the regression trials use because it sees the plaque itself rather than its shadow. The second is CT imaging from outside, which counts the calcium in the artery wall as a calcium score and, in its newer forms, measures plaque volume and distinguishes the soft, lipid-rich plaque that ruptures from the dense, calcified plaque that does not. A claim that something removes plaque is a claim that a number on one of these instruments went down in people who took the thing compared with people who did not, and the ruler is laid out so that every product sold with the verb can be held against it.

What regression looks like when it happens is less than the word removes implies, and understanding that is the page's second point. In the serial ultrasound trials, high-intensity statin treatment reduced coronary plaque volume by a few percent over about two years, a small change in size, accompanied by a larger change in composition: the lipid core shrank, the fibrous cap thickened and the plaque became more stable, which is the change that reduces heart attacks, since a plaque ruptures from its cap and not from its size. Nobody's plaque was removed; a modest regression and a stabilisation were measured, and that is the strongest result on the ruler in any drug class. The second thing that moved the needle is a prescription-dose purified EPA, four grams a day of the ethyl ester for eighteen months in patients with raised triglycerides already on statins, which reduced the low-attenuation plaque volume on CT against a mineral oil placebo; it is a medicine at a dose no supplement reaches, in a high-risk group, and it is the one omega-3 result on the ruler, with the supplement-dose outcome trials showing no event reduction and the UK guidance saying not to offer omega-3 supplements for prevention.

Those two are the whole of the ruler's upper end: a modest regression and stabilisation from statins, and a plaque-volume reduction from a prescription EPA in a specific group. Both are prescribed, both act on the drivers of the plaque, the cholesterol-carrying particles and the triglycerides, rather than on the lesion directly, and both were measured on an instrument in a randomised trial. Everything sold with the word removes is held against them in the next section, and none of it has a number on either instrument.

A ruler with two instruments and two entries at its top, both medicines, and the products sold with the verb held against it, the symptoms that are an appointment, and the worked example, which is the next section.

The products sold with the word removes held against the ruler: enzymes, oral chelation, vitamin K2, polyphenols and extracts; why a stabilised plaque matters more than a smaller one; the three symptoms for a doctor today; the worked example; and the verdict

The enzymes come first because they use the verb most literally. Nattokinase, from fermented soy, and serrapeptase, from a silkworm bacterium, are sold as dissolving plaque, and no human trial has measured plaque on either instrument in people taking them; what trials exist are small and look at clotting markers and blood pressure, which is a different thing and which makes them a pharmacist's question for anyone on an anticoagulant or antiplatelet medicine rather than a purchase for the artery wall. Oral chelation products, sold on the back of an intravenous trial, have no trial of their own at all, and the intravenous trial in people after a heart attack, using EDTA infusions over many sessions, produced a modest reduction in a combined endpoint that its own investigators described as not supporting routine use; a capsule of a chelator that is barely absorbed from the gut is a different substance from an infusion and has nothing on the ruler. Vitamin K2 as menaquinone-7 was tested on the second instrument, CT calcification, in randomised trials, and did not slow the progression of coronary or valve calcification, which is the one supplement result on the ruler and it is null. The polyphenols, pomegranate, garlic, grape seed, green tea extract and the rest, have marker trials, small changes in cholesterol, blood pressure or a surrogate of artery function, and no plaque measurement on either instrument. Coenzyme Q10, niacin, arginine, the fibre supplements and the magnesium sold for arteries have nothing on either. Held against the ruler, the shelf is empty at every point.

Why a stabilised plaque matters more than a smaller one is the thing a buyer searching for removal should take away, because it changes what they are looking for. The event that harms a person is rupture, the cap tearing and a clot forming, and rupture depends on the cap's thickness and the core's size rather than on the plaque's volume; a large stable plaque can sit for decades while a small unstable one ruptures. The therapies on the ruler reduce events by stabilising the cap and shrinking the core, and the modest volume regression is almost a by-product. A buyer who wanted their plaque removed should want it stabilised, and stabilisation is what the medicines a doctor prescribes do and what no supplement has been shown to do on any instrument.

Three symptoms turn the search into an appointment today, stated plainly: chest pain or pressure, especially on exertion or spreading to the arm, jaw or back; breathlessness out of proportion to effort; and sudden weakness, numbness, slurred speech or loss of vision, which is an emergency. A person with a known plaque, a calcium score, a family history of early heart disease, high cholesterol, high blood pressure or diabetes has a doctor's conversation about the medicines on the ruler before any purchase, and a lifter moves the drivers with training, the plate and not smoking, which act upstream of every stage.

The worked example is placed off the ruler, which is where every supplement sits: {FL}, 1500mg magnesium bisglycinate stated as 300mg elemental at 80% NRV, two capsules with the evening meal, with authorised claims for normal muscle function, electrolyte balance and the reduction of tiredness and fatigue, no claim for the arteries, the heart or anything measured on either instrument, which this page does not make, batch tested for lead, mercury, arsenic and cadmium, UK made, 180 capsules for £19.99 at 22p a day, taken for a plate the survey finds a share of adults short of. The full label breakdown is here.

The verdict: no supplement removes plaque from arteries, because removal is measured on two instruments, intravascular ultrasound and CT, and on those instruments only high-intensity statins, by a few percent of volume with a stabilised cap over about two years, and a prescription-dose purified EPA in a high-risk group have moved the needle. The enzymes, the oral chelation products, vitamin K2 and the extracts have no number on either, and a stabilised plaque, which the medicines produce, matters more than a smaller one. Chest pain, breathlessness or a sudden neurological symptom is a doctor's today.

What to check on the label

Questions people also ask

Can plaque in arteries be reversed naturally with supplements?

Not on any instrument that measures it: plaque regression is measured by intravascular ultrasound inside the artery or by CT from outside, and in randomised trials only high-intensity statins, by a few percent of plaque volume with a stabilised cap over about two years, and a prescription-dose purified EPA in a high-risk group already on statins have moved the needle; no enzyme, oral chelation product, vitamin K2 trial, polyphenol or extract has produced a measured reduction in plaque volume or calcium, and the drivers of plaque are moved by training, the plate, not smoking and the medicines a doctor prescribes.

Does nattokinase or serrapeptase dissolve arterial plaque?

No human trial has measured plaque on either instrument in people taking either enzyme; the small trials that exist look at clotting markers and blood pressure, which is a different thing, and the effect on clotting makes both a pharmacist's question for anyone taking an anticoagulant or antiplatelet medicine rather than a purchase for the artery wall; the word dissolve on the label is a claim about a number that has never been measured.

Does chelation remove plaque from arteries?

The oral chelation products sold for it have no trial of their own, and the intravenous trial they borrow from, EDTA infusions over many sessions in people after a heart attack, produced a modest reduction in a combined cardiovascular endpoint that its own investigators described as not supporting routine use, with no plaque measurement; a capsule of a chelator barely absorbed from the gut is a different substance from an infusion and sits nowhere on the regression ruler.

Why does a stabilised plaque matter more than a smaller one?

Because the event that harms a person is rupture, the cap tearing and a clot forming, and rupture depends on the cap's thickness and the lipid core's size rather than on the plaque's volume, so a large stable plaque can sit for decades while a small unstable one ruptures; the therapies on the ruler reduce heart attacks by thickening the cap and shrinking the core, with the modest volume regression almost a by-product, which means a buyer who wanted removal should want stabilisation, and stabilisation is what the prescribed medicines do and no supplement has been shown to do.

Does magnesium clear arteries?

No, and it makes no such claim; magnesium has authorised claims for normal muscle function, electrolyte balance and the reduction of tiredness and fatigue, nothing for the arteries or the heart, and nothing measured on either plaque instrument, so the worked example sits off the ruler with every other supplement at 300mg elemental, 80% NRV, two capsules with the evening meal for 22p a day, batch tested for four metals and UK made, taken for a plate the national survey finds a share of adults short of.

Sources

1. The intravascular ultrasound statin trials: high-intensity statin therapy reduced coronary plaque volume by a small percentage over about two years in serial imaging studies, with the regression modest in size and accompanied by a change in plaque composition toward a more stable form, the only drug class with consistent regression evidence of this kind. PubMed record
2. The plaque imaging trial of prescription EPA: four grams a day of purified EPA ethyl ester for eighteen months in patients with raised triglycerides on statins reduced low-attenuation coronary plaque volume on CT against a mineral oil placebo, a prescription-dose finding in a high-risk population with no supplement-dose plaque regression evidence. PubMed record
3. The chelation therapy trial in patients after a heart attack: intravenous disodium EDTA infusions produced a modest reduction in a combined cardiovascular endpoint, largest in people with diabetes, in a trial whose result was described by its own investigators as not supporting routine use, with oral chelation products having no trial evidence at all. PubMed record
4. The vitamin K2 and vascular calcification trials: supplementation with menaquinone-7 did not slow the progression of coronary artery calcification or aortic valve calcification in the randomised trials that measured it by CT, against a mechanism that remains plausible and observational data that suggested benefit. PubMed record

Related answers

• What is the best supplement to help reduce arterial plaque buildup?
• Is it safe to buy supplements from Amazon?
• What is the best 3rd party tested supplement brands?
• Which online supplement store is the best in the UK?
• What are some reputable, third-party tested supplement brands in the UK?
• How do you check if a supplement brand is UK based?